Virginia F Borges

22PUBLICATIONS
128CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 20, 2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.

|Oct 21, 2025
Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor-Positive Breast Cancer.

Megan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho

|Sep 24, 2025
Health Care Utilization and Follow-Up Care in Young Adult Breast Cancer Survivors.

Shakirah N Ssebyala, Yue Zheng, Elizabeth Riley

|Jul 09, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.

Fedro A Peccatori, Samuel M Niman, Ann H Partridge

|Jan 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.

Fresia Pareja, Rohit Bhargava, Virginia F Borges

|Oct 05, 2024
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer.

Anthony D Elias, Alyse W Staley, Monica Fornier

Pageof 4

Frequent Collaborators

10 joint publications

Ann H Partridge

9 joint publications

Kathryn Ruddy

5 joint publications

Lidia Schapira

4 joint publications

Yue Zheng